RecruitingNCT03374267

Registry Platform Urologic Cancer

Clinical Research Platform On Urologic Cancer Treatment And Outcome (Registry Platform Urologic Cancer; CARAT)


Sponsor

iOMEDICO AG

Enrollment

1,930 participants

Start Date

Dec 7, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with advanced renal cell carcinoma or urothelial cancer in Germany.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is a registry (a large database) collecting information about patients with advanced kidney cancer or advanced bladder and urinary tract cancer who are starting their first round of systemic treatment, to understand how different treatments work in real-world settings. **You may be eligible if...** - You are 18 years or older (male or female) - You have been diagnosed with advanced kidney cancer or advanced urothelial cancer (bladder and urinary tract cancer) that is locally advanced, inoperable, or has spread to other organs - You are starting your first round of systemic treatment (such as immunotherapy or targeted therapy) - You have provided written informed consent - You may also be eligible if you have high-risk muscle-invasive urothelial cancer, either as a new or historical case **You may NOT be eligible if...** - You have already started second-line or later treatment - You have not provided written consent - You do not have one of the qualifying cancer diagnoses Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRoutine care as per site standard.

Physician's choice according to patient's needs.


Locations(1)

Multiple sites, Germany

Multiple Locations, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03374267


Related Trials